The U.S. Food and Drug Administration (FDA) is unlikely to renew the authorization granted to use Pfizer (NYSE:PFE) and BioNTech’s (BNTX) COVID-19 vaccine in young children this fall, The Guardian ...

Key opportunities arise from personalized treatment growth, advances in sequencing technology, strategic alliances, adaptable ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.

After BioNTech’s acquisition of CureVac closes, BioNTech will pay GSK another $130 million and a 1% royalty on rest-of-world ...

IO Biotech (IOBT) stock rallies as cancer vaccine, Cylembio, with Merck's (MRK) Keytruda outperforms in a late-stage trial ...

Patients in England with advanced head and neck cancer are being fast-tracked into a groundbreaking mRNA cancer vaccine trial, a ...

GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review ...

Bildnachweis: Trophic Communications, VC Magazin, Pixabay. With over three decades in strategic communications and a track record with leaders like BioNTech and Tubulis, Gretchen Schweitzer brings ...

CureVac ( (CVAC)) has provided an announcement. On August 7, 2025, CureVac announced the resolution of U.S. patent litigation with Pfizer/BioNTech concerning mRNA-based COVID-19 vaccines. As part of ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Firing of Bureau of Labor Statistics chief could fatally undermine trust in an organisation crucial to transparency of US ...

“Stratus,” originally known as Variant XFG, is the second most prominent strain of COVID in the United States. According to ...